Your browser doesn't support javascript.
loading
Prognostic risk factors of buccal squamous cell carcinoma: A case-control study.
Callander, Jacquelyn K; Souza, Spenser S; Eltawil, Yasmin; El-Sayed, Ivan H; George, Jonathan R; Ha, Patrick; Ryan, William R; Xu, Mary Jue; Heaton, Chase M.
Afiliação
  • Callander JK; Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco, San Francisco, California, USA.
  • Souza SS; Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco, San Francisco, California, USA.
  • Eltawil Y; University of California San Francisco School of Medicine, San Francisco, California, USA.
  • El-Sayed IH; Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco, San Francisco, California, USA.
  • George JR; Division of Head and Neck Oncologic and Endocrine Surgery, Department of Otolaryngology-Head and Neck Surgery, San Francisco, California, USA.
  • Ha P; Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco, San Francisco, California, USA.
  • Ryan WR; Division of Head and Neck Oncologic and Endocrine Surgery, Department of Otolaryngology-Head and Neck Surgery, San Francisco, California, USA.
  • Xu MJ; Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco, San Francisco, California, USA.
  • Heaton CM; Division of Head and Neck Oncologic and Endocrine Surgery, Department of Otolaryngology-Head and Neck Surgery, San Francisco, California, USA.
Head Neck ; 2024 Feb 27.
Article em En | MEDLINE | ID: mdl-38411290
ABSTRACT

OBJECTIVES:

To describe the clinicopathologic presentation of buccal squamous cell carcinoma and identify risks factors for recurrence and overall survival.

METHODS:

This is a retrospective case-control study of patients with oral cavity squamous cell carcinoma (OCSCC) treated at a single tertiary care center between 2010 and 2022. All patients with buccal subsite OCSCC treated during this time frame were included and paired with a randomly selected age and gender matched patient with non-buccal OCSCC. Relevant data was collected via chart review.

RESULTS:

Seventy-seven patients with buccal SCC were matched with 77 non-buccal OCSCC controls. The median follow-up time was 27 months (IQR 14-61). Median age was 67 years (IQR 57-75) and 53% of the cohort was female. Twenty (26%) buccal SCC patients experienced a recurrence versus 19 (25%) in the controls. Age ≥65-years-old increased odds of all-cause mortality in the buccal SCC group, but not in the control group. Perineural invasion and positive margins increased odds of recurrence in the buccal group only. Overall survival and progression-free survival did not differ between the groups, despite a greater number of T2 buccal tumors and T1 non-buccal tumors.

CONCLUSIONS:

Buccal SCC presents at a higher T stage than other oral cavity SCC subsite and may exhibit variance in the pathologic risk factors that predict poor outcomes versus non-buccal OCSCC. Despite these relatively minor differences, however, oncologic outcomes between these groups were similar.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Head Neck Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Head Neck Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos
...